Comparison of seegene anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping

Journal of Clinical Microbiology

Volumn 52, Issue 2, 2014, Pages 607-612

  Estrade, C ^a   Sahli, R ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLICON; ARTICLE; DIAGNOSTIC KIT; DNA SEQUENCE; GENOTYPE; HUMAN PAPILLOMAVIRUS TYPE 28; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 68A; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WART VIRUS;

COINFECTION; DNA, VIRAL; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; VAGINAL SMEARS; VIROLOGY;

EID: 84893125090     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02749-13     Document Type: Article

References (27)

1. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24S. 3:S1-S10. http://dx.doi.org/10. 1016/j.vaccine.2006.05.115.
2. zur Hausen H. 2009. Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384:260-265. http://dx.doi.org/10.1016/j. virol.2008.11.046.
3. Berkhof J, Bulkmans NW, Bleeker MC, Bulk S, Snijders PJ, Voorhorst FJ, Meijer CJ. 2006. Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear. Cancer Epidemiol. Biomarkers Prev. 15:1268-1273. http://dx.doi.org/10.1158/1055-9965.EPI-05-0764.
4. Boone JD, Erickson BK, Huh WK. 2012. New insights into cervical cancer screening. J. Gynecol. Oncol. 23:282-287. http://dx.doi.org/10.3802/jgo.2012.23. 4.282.
5. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Hansson BG, Rylander E, Dillner J. 2007. HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study. Br. J. Cancer 97:129-132. http://dx.doi.org/10.1038/sj.bjc.6603843.
6. Carozzi FM, Burroni E, Bisanzi S, Puliti D, Confortini M, Giorgi Rossi P, Sani C, Scalisi A, Chini F. 2011. Comparison of clinical performance of Abbott RealTime high risk HPV test with that of hybrid capture 2 assay in a screening setting. J. Clin. Microbiol. 49:1446-1451. http://dx.doi.org/10.1128/JCM.02311- 10.
7. Cuzick J, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, McCarthy J, Buckley H, Bergeron C, Soutter WP, Lyons D, Szarewski A. 2010. Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears. J. Med. Virol. 82:1186-1191. http://dx.doi.org/10. 1002/jmv.21801.
8. Heideman DA, Hesselink AT, Berkhof J, van Kemenade F, Melchers WJ, Daalmeijer NF, Verkuijten M, Meijer CJ, Snijders PJ. 2011. Clinical validation of the Cobas 4800 HPV test for cervical screening purposes. J. Clin. Microbiol. 49:3983-3985. http://dx.doi.org/10.1128/JCM.05552-11.
9. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ. 2009. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int. J. Cancer 124:516-520. http://dx.doi.org/10.1002/ijc.24010.
10. Unger ER, Dillner J, Zhou T (ed). 2009. Human papillomavirus laboratory manual, 1st ed. WHO, Geneva, Switzerland.
11. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2001. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286:3106-3114. http://dx.doi.org/10.1001/jama.286.24.3106.
12. Coutlee F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vezina S, Cote P, Macleod J, Voyer H, Forest P, Walmsley S, Franco E. 2006. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J. Clin. Microbiol. 44:1998-2006. http://dx.doi.org/10.1128/JCM.00104-06.
13. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361.
14. Jiang HL, Zhu HH, Zhou LF, Chen F, Chen Z. 2006. Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system. J. Med. Microbiol. 55:715-720. http://dx.doi.org/10.1099/jmm.0.46493-0.
15. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
16. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512. http://dx.doi.org/10.1128/JCM.44.2.504-512.2006.
17. Soderlund-Strand A, Carlson J, Dillner J. 2009. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J. Clin. Microbiol. 47:541-546. http://dx.doi.org/10.1128/JCM. 02007-08.
18. van Den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. 2002. GP5-/6-PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787. http://dx.doi.org/10.1128/JCM.40.3.779-787.2002.
19. Wallace J, Woda BA, Pihan G. 2005. Facile, comprehensive, highthroughput genotyping of hum. Genital papillomaviruses using spectrally addressable liquid bead microarrays. J. Mol. Diagn. 7:72-80. http://dx.doi.org/10.1016/S1525- 1578(10)60011-6.
20. Estrade C, Menoud PA, Nardelli-Haefliger D, Sahli R. 2011. Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J. Clin. Microbiol. 49:3474-3481. http://dx.doi.org/10.1128/JCM.05039-11.
21. Micalessi IM, Boulet GA, Bogers JJ, Benoy IH, Depuydt CE. 2012. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin. Chem. Lab. Med. 50:655-661. http://dx.doi.org/10.1515/cclm.2011.835.
22. Eklund C, Forslund O, Wallin KL, Zhou T, Dillner J, WHO Human Papillomavirus Laboratory Network. 2012. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J. Clin. Microbiol. 50:2289-2298. http://dx.doi.org/10.1128/JCM.00840-12.
23. Eklund C, Zhou T, Dillner J, WHO Human Papillomavirus Laboratory Network. 2010. Global proficiency study ofhumanpapillomavirus genotyping. J. Clin. Microbiol. 48:4147-4155. http://dx.doi.org/10.1128/JCM.00918-10.
24. Chun JY, Kim KJ, Hwang IT, Kim YJ, Lee DH, Lee IK, Kim JK. 2007. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res. 35:e40. http://dx.doi.org/10.1093/nar/gkm051.
25. Cho CH, Chulten B, Lee CK, Nam MH, Yoon SY, Lim CS, Cho Y, Kim YK. 2013. Evaluation of a novel real-time RT-PCR using TOCE technology compared with culture and Seeplex RV15 for simultaneous detection of respiratory viruses. J. Clin. Virol. 57:338-342. http://dx.doi.org/10.1016/j.jcv.2013.04.014.
26. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B, Hagmar B. 1996. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J. Clin. Microbiol. 34:2095-2100.
27. Snijders PJ, van den Brule AJ, Meijer CJ. 2003. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J. Pathol. 201:1-6. http://dx.doi.org/10.1002/path.1433.